Marathon Trading Investment Management »

Taysha Gene Therapies shares owned by Marathon Trading Investment Management

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Marathon Trading Investment Management from 13F filings

Historical chart of Marathon Trading Investment Management investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Marathon Trading Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Marathon Trading Investment Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $643k 224k 2.87

More positions owned by Marathon Trading Investment Management

Spdr S&p 500 Etf Tr Option Put Option
United States Stl Corp Option Put Option
Chevron Corp Option Put Option
Ishares Tr Option Call Option
Bank America Corp Option Put Option
United States Stl Corp Option Call Option
Citigroup Common Stock (C)
Citigroup Option Put Option
Bank America Corp Common Stock (BAC)
Capri Holdings Option Put Option
Spdr S&p 500 Etf Tr Option Call Option
Invesco Qqq Tr Common Stock (QQQ)
Hess Corp Option Call Option
Wells Fargo Option Put Option
Bank America Corp Option Call Option

View all positions for Marathon Trading Investment Management

Top funds holding Taysha Gene Therapies

FMR
RA Capital Management
VR Adviser
Vanguard Group
Morgan Stanley
venBio Select Advisor
Baker Bros. Advisors
Artal Group
Millennium Management
Octagon Capital Advisors
BlackRock
Damian Sousa
Cowen And Company
Susquehanna International
Point72 Asset Management

View all funds holding Taysha Gene Therapies